Kevin Long

Healthcare Active Runners: Merck & Co. (NYSE:MRK), Johnson & Johnson (NYSE:JNJ), Pfizer Inc. (NYSE:PFE), Ariad Pharmaceuticals (NASDAQ:ARIA)

Merck & Co., Inc. (NYSE:MRK) is getting close to conducting phase 3 trials for a combination treatment for Hepatitis C, which could potentially rejuvenate the pharmaceutical giant’s revenue growth. The clinical data for a combination of drugs MK-5172 and MK-8742 has showed high cure rates among patients with genotype 1 of the disease, and this…

Read More

Biotech Most Active Stocks: Gilead Sciences (NASDAQ:GILD), EXACT Sciences Corporation (NASDAQ:EXAS), Endocyte (NASDAQ:ECYT), Arena Pharmaceuticals (NASDAQ:ARNA)

Gilead Sciences Inc. (NASDAQ:GILD) announced that it has elected to settle its conversion obligations in connection with any 1.00% Senior Convertible Notes due 2014 (the “Notes”) submitted for conversion on or after February 1 2014 entirely in cash. Gilead Sciences, Inc. (NASDAQ:GILD) stock performance was -4.01% in last session and finished the day at $68.55….

Read More

Mortgage Investment: KKR Financial Holdings (NYSE:KFN), CYS Investments Inc (NYSE:CYS), Ocwen Financial (NYSE:OCN), Western Asset Mortgage Capital (NYSE:WMC)

KKR Financial Holding LLC (NYSE:KFN) presently has a stellar rank, in the top 10% of the coverage universe, which suggests it is among the top most “interesting” ideas that merit further research by investors. But making KKR Financial Holdings LLC (NYSE:KFN) an even more interesting and timely stock to look at, is the fact that…

Read More

Top Losers: Plug Power Inc. (NASDAQ:PLUG), Facebook Inc. (NASDAQ:FB), Exelixis (NASDAQ:EXEL), FuelCell Energy Inc. (NASDAQ:FCEL)

Plug Power Inc. (NASDAQ:PLUG) the fuel-cell maker was in the news again yesterday, after CEO Andy Marsh told MarketWatch that the company had “signed an additional order in North America with a global automaker. Plug Power Inc. (NASDAQ:PLUG) stock performance was -23.94% in last session and finished the day at $6.45. Traded volume was 119.25…

Read More

Biotech New Lows: Akebia Therapeutics (NASDAQ:AKBA), Galmed Pharmaceuticals (NASDAQ:GLMD), Tetralogic Pharmaceuticals (NASDAQ:TLOG), Dipexium Pharmaceuticals (NASDAQ:DPRX)

Akebia Therapeutics Inc. (NASDAQ:AKBA) offered 5.9 million shares in its Thursday IPO at $17 a share, the high end of the stock’s expected price range. Among other therapeutics, the biopharma company is developing a once-daily oral therapy for patients with kidney disease. Akebia Therapeutics, Inc. (NASDAQ:AKBA) stock performance was -0.99% in last session and finished…

Read More

Tech Sector Most Active: Facebook Inc (NASDAQ:FB), AT&T Inc. (NYSE:T), Microsoft Corporation (NASDAQ:MSFT), Nokia Corporation (ADR) (NYSE:NOK)

Facebook Inc (NASDAQ:FB) Chief Operating Officer Sheryl Sandberg said she declined in 2008 to limit the recruitment or hiring of Google Inc. (GOOG) employees after being contacted by two senior officials at the search engine company. Facebook Inc (NASDAQ:FB) stock performance was -4.67% in last session and finished the day at $64.10. Traded volume was…

Read More
Home